| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 26/03/2015 | 15h12 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 17/02/2015 | 18h10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 20/02/2014 | 23h00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 04/11/2013 | 20h23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 30/10/2013 | 11h00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 00h51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 00h39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 23h09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 22h58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 22h42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 22h11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 21h51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 20h53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 20h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 20h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 19h21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 23h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20h29 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 18h55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 15h47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 23/10/2013 | 22h32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 15/10/2013 | 15h23 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |